Welcome to the CJU website » LOG IN


Current prostate cancer genetic testing capabilities and considerations
Division of Human Genetics, James Comprehensive Cancer Center, Columbus, Ohio, USA
Oct 2019 (Vol. 26, Issue 52, Pages( 38 - 39)
PMID: 31629427


Text-Size + 

  • With the advent of next-generation sequencing technologies, genetic testing of prostate cancer patients is now typically done using multi-gene panels. These vary from targeted disease-specific panels to comprehensive (pan-cancer) panels, with advantages and disadvantages for each. This paper reviews a number of issues raised in choosing the best panels and labs to use, and issues presented by the increasing availability of direct-to-consumer testing.

Current Issue

August 2021, Vol.28 No.4
canadian journal of urology